GRXCR1

Chr 4AR

glutaredoxin and cysteine rich domain containing 1

Also known as: DFNB25, PPP1R88

This gene is one of 60 loci associated with autosomal-recessive nonsyndromic hearing impairment. This gene encodes a protein which contains GRX-like domains; these domains play a role in the S-glutathionylation of proteins and may be involved in actin organization in hair cells. [provided by RefSeq, Sep 2010]

Primary Disease Associations & Inheritance

Deafness, autosomal recessive 25MIM #613285
AR
0
Active trials
35
Pathogenic / LP
188
ClinVar variants
1
Pubs (1 yr)
-0.5
Missense Z
1.70
LOEUF
Clinical SummaryGRXCR1
🧬
Gene-Disease Validity (ClinGen)
nonsyndromic genetic hearing loss · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
35 Pathogenic / Likely Pathogenic· 93 VUS of 188 total submissions
📖
GeneReview available — GRXCR1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.70LOEUF
pLI 0.000
Z-score -0.43
OE 1.13 (0.751.70)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.48Z-score
OE missense 1.11 (0.981.26)
174 obs / 157.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.13 (0.751.70)
00.351.4
Missense OE1.11 (0.981.26)
00.61.4
Synonymous OE1.08
01.21.6
LoF obs/exp: 15 / 13.3Missense obs/exp: 174 / 157.1Syn Z: -0.49
GOFDN
DN
0.6452th %ile
GOF
0.6540th %ile
LOF
0.4726th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

188 submitted variants in ClinVar

Classification Summary

Pathogenic26
Likely Pathogenic9
VUS93
Likely Benign48
Benign10
Conflicting2
26
Pathogenic
9
Likely Pathogenic
93
VUS
48
Likely Benign
10
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
3
1
22
0
26
Likely Pathogenic
1
2
6
0
9
VUS
2
77
13
1
93
Likely Benign
0
2
22
24
48
Benign
0
3
7
0
10
Conflicting
2
Total6857025188

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

GRXCR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

GRXCR1-related deafness

definitive
ARLoss Of FunctionAbsent Gene Product
Ear
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence